- BGI Genomics Announces Pricing of Initial Public Offering
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: firstname.lastname@example.org
SEATTLE, WA April 10, 2017 – BGI, a global genomics company, and the Allen Institute, a nonprofit medical research organization, have signed a memorandum of understanding to discuss and explore possible scientific collaborations using genomics-based research.
The two organizations expect to explore comprehensive sequencing technologies and possible collaborative research projects in areas such as bioinformatics and data mining. The research projects envisioned involve defining cell types in the brain and understanding neurodegenerative or developmental diseases and disorders. The relationship may also include educational exchanges between BGI, headquartered in Shenzhen, China, and the Allen Institute, based in Seattle, USA.
“We think there is great potential to leverage BGI’s genomics and research capabilities to support the Allen Institute’s pioneering work in understanding of the human brain,” said Yiwu He, head of research and development for BGI. “We hope the potential collaborations can accelerate discovery in important areas and advance scientific research for the benefit of human health.”
BGI is engaged in scientific research, genomic sequencing, precision medicine, agriculture, bioinformatics and related technologies, with more than 5,000 employees and R&D, manufacturing, and commercial operations around the world. BGI’s is focused on improving human health and empowering large-scale human, plant, and animal genomics research.
The Allen Institute for Brain Science, a division of the Allen Institute, is dedicated to accelerating the understanding of how the human brain works in health and disease. Using a big science approach, the Allen Institute generates useful public resources for researchers and organizations around the globe, drives technological and analytical advances, and discovers fundamental brain properties through integration of experiments, modeling and theory.
About The Allen Institute for Brain Science
The Allen Institute for Brain Science is a division of the Allen Institute, an independent, nonprofit medical research organization dedicated to accelerating the understanding of how the human brain works in health and disease. Using a big science approach, the Allen Institute generates useful public resources used by researchers and organizations around the globe, drives technological and analytical advances, and discovers fundamental brain properties through integration of experiments, modeling and theory. Launched in 2003 with a seed contribution from founder and philanthropist Paul G. Allen, the Allen Institute is supported by a diversity of government, foundation and private funds to enable its projects. Given the Institute’s achievements, Mr. Allen committed an additional $300 million in 2012 for the first four years of a ten-year plan to further propel and expand the Institute’s scientific programs, bringing his total commitment to date to $500 million. The Allen Institute’s data and tools are publicly available online at www.brain-map.org.
For more information: https://alleninstitute.org
+1 206 778-7411